HotSpot Therapeutics
Carolin Barth currently serves as an Associate and Data and Strategy Analyst at HotSpot Therapeutics, Inc., since January 2020. Prior to this role, Carolin was a Postdoctoral Fellow at the Max Delbrück Center from June 2011 to December 2019, working in the laboratory of Dr. Oliver Rocks on spatio-temporal control of Rho GTPase signaling, and previously completed a PhD in the same laboratory, focusing on the role of ARHGAP39 in cell migration. Carolin earned a Master of Science and a Bachelor of Science in Biology from Technische Universität Braunschweig, completing the master's degree in 2011 and the bachelor's degree in 2009.
This person is not in any offices
HotSpot Therapeutics
1 followers
Inspired by nature’s ability to regulate protein function to restore health, HotSpot Therapeutics is discovering new allosteric therapies with the ability to treat disease in new ways.